Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Rutgers Team Discovers Novel Approach to Stimulate Immune Cells

14.05.2012
Research builds towards potential treatment for immune diseases and cancer

Researchers at Rutgers University have uncovered a new way to stimulate activity of immune cell opiate receptors, leading to efficient tumor cell clearance.

Dipak Sarkar, professor in the Department of Animal Sciences at the Rutgers School of Environmental and Biological Sciences and his research team have been able to take a new pharmacological approach to activate the immune cells to prevent cancer growth through stimulation of the opiate receptors found on immune cells.

This research, funded by the National Institutes of Health-National Institute on Alcohol Abuse and Alcoholosm, is featured on the cover of the May 11 issue of the Journal of Biological Chemistry. It describes two structurally different but functionally similar opioid receptors, Mu- and Delta-opioid receptors. These receptors form protein complexes as either two structurally similar receptors as a homodimer—formed by two identical molecules—or two structurally dissimilar protein complexes as a heterodimer—formed by ethanol inducement—in immune cells. The team pharmacologically fooled these two structurally different but functionally similar opioid receptors to form more homodimers so that opioid peptide increases the immune cells’ ability to kill tumor cells.

“The potential for this research can lead to production of endogenous opioids in the brain and the periphery becoming more effective in regulating stress and immune function,” says Sarkar.

Opioids, like endorphins, communicate with the immune system, so when there is a deficit of endorphin – due to fetal alcohol exposure, alcoholism and drug abuse, anxiety, depression and chronic psychological stress – the body undergoes stress shocks and, as Sarkar suggests, causes “immune incompetence.”

“Opioids act as the regulator of body stress mechanism, so when endorphins are low, body stress indicators are high,” says Sarkar, who directs the Endocrine Research Program at Rutgers and is a faculty member of the Rutgers Center of Alcohol Studies.

“What’s new about this latest research is that when we combine the Mu receptor blocker (antagonist) with the Delta receptor stimulator (agonist), the immune cells accrue increased foreign cell-killing ability,” explains Sarkar. “This makes the body highly effective in fighting against bacterial infection and tumor growth.”

Sarkar believes that combining this opioid antagonist and agonist may have potential therapeutic value in humans for the treatment of immune incompetence, cancer, pain and ethanol-dependent diseases.

Previous research by the Sarkar group showed that replenishing endorphins by cell therapy did prevent many of the stress and immune problems in fetal alcohol-exposed test subjects. However, cell therapy is highly complex, involving the cumbersome process of producing endorphin cells from neural stem cells of patients and can sometimes result in rejection and other issues.

The beginning of the team’s interest into how stress causes diseases started with the observation that mothers who suffer from alcohol abuse or with other developmental problems often give birth to children who exhibited hype-stress responses, linked to childhood disease, child abnormality, immune diseases and cancer.

As part of their investigation, the Sarkar research team learned that the endogenous opioid system in the brain is abnormal in kids and adults who demonstrate hyper-stress responses.

“With the link between hyper-stress responses and manifested immune issues, the goal has been to replenish the opioid deficit in the brain and lead to an effective therapy for immune and other diseases,” explained Sarkar.

The team also found that when people consume alcohol, the effectiveness of the body’s ability to defend against viral and bacterial invasion, and fight against cancer decreases.

“The overall goal of our research program is to increase our understanding of and develop new therapy for the treatment of cancer, immune and other alcoholism-induced diseases,” says Sarkar.

They hope that the promise of their novel pharmacological approach that modifies the activity of the opioid receptors of immune cells brings them one step closer in the long road to therapeutic advances.
Media Contact: Paula Walcott-Quintin
848-932-4204
E-mail: quintin@aesop.rutgers.edu

Paula Walcott-Quintin | EurekAlert!
Further information:
http://www.rutgers.edu

More articles from Life Sciences:

nachricht Modern genetic sequencing tools give clearer picture of how corals are related
17.08.2017 | University of Washington

nachricht The irresistible fragrance of dying vinegar flies
16.08.2017 | Max-Planck-Institut für chemische Ökologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Climate change: In their old age, trees still accumulate large quantities of carbon

17.08.2017 | Earth Sciences

Modern genetic sequencing tools give clearer picture of how corals are related

17.08.2017 | Life Sciences

Superconductivity research reveals potential new state of matter

17.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>